BRNS Financials
Barinthus Biotherapeutics plc - Financial statements & key metrics
Stock Price
$0.72
Market Cap
$38.16M
P/E Ratio
-0.5
EPS
$-1.88
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$14.97M
Gross Profit
-
Operating Income
-
Net Income
$-61.18M
EPS (Diluted)
$-1.55
Balance Sheet Highlights
Total Assets
$160.33M
Total Liabilities
$30.19M
Shareholders Equity
-
Cash & Equivalents
$110.66M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-28.94M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-62.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BRNS revenue?
BRNS's most recent quarterly revenue was $14.97M. Annual revenue can be calculated by summing the four most recent quarters.
Is BRNS profitable?
BRNS reported a loss of $61.18M in the most recent quarter.
What is BRNS market cap?
BRNS has a market capitalization of $38.16M, making it a small-cap stock.
Does BRNS have debt?
View BRNS's balance sheet for debt information.
What is BRNS cash flow?
Cash flow data is available in the full financial statements.